ALCHEMIA LIMITED (ACL)

The development of carbohydrate-based molecules for therapeutic applications.

On this page you will find:

Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
ACL	0.360	-1.37%	0.360	0.370	0.365	0.370	0.360	34,223

ALCHEMIA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	ACL
Securities	ASX Code, Security Description ------------------------------ ACL, Ordinary Fully Paid
Official Listing Date	23 December, 2003
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Registered Office Address	Brisbane Technology Park, 3 Hi-Tech Court, EIGHT MILE PLAINS, QLD, AUSTRALIA, 4113
Head Office Telephone	(07) 3340 0200
Head Office Fax	(07) 3340 0200
Share Registry	LINK MARKET SERVICES LIMITED LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000
Share Registry Telephone	1300 554 474

Directors / Senior Management
Dr Mel Bridges (Chairman) Mr Charles Walker (CEO, CFO) Mr Nathan Drona (Non Exec. Director) Dr Susan Kelley (Non Exec. Director) Ms Tracie Ramsdale (Non Exec. Director) Ms Nerolie Withnall (Non Exec. Director)

Company Secretary	Mr Stephen Denaro
Principal Activities	The development of carbohydrate-based molecules for therapeutic applications.

ALCHEMIA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
22/05/2013		Investor Presentation	28	PDF
22/05/2013		Company Update	4	PDF
07/05/2013		Change in substantial holding	3	PDF
01/05/2013		VAST US Patent Granted	2	PDF
30/04/2013		Appendix 4C - quarterly	5	PDF
23/04/2013		AstraZeneca Multi-Target Drug Discovery Collaboration	2	PDF
12/04/2013		Appendix 3B	12	PDF
12/04/2013		SPP Closes Heavily Oversubscribed	3	PDF
04/04/2013		Launch of Fondaparinux in India	2	PDF
04/04/2013		IP Update	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
24 May 2013	0.360	-1.37%	0.370	0.360	34,223
23 May 2013	0.365	-2.67%	0.370	0.360	123,590
22 May 2013	0.375	-1.32%	0.385	0.365	322,654
21 May 2013	0.380	0%	0.385	0.375	55,785
20 May 2013	0.380	2.7%	0.385	0.380	111,734

* Volume of shares shown represents only those shares traded on ASX.

ALCHEMIA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACL

Warrants & Structured Products

No warrants & Structured Products are available over the security ACL

ASX CFDs

No Contracts For Differences are available over the security ACL

MyASX: Login | Sign up